MDRNA, Inc. Receives NASDAQ Notification
11/13/2009 10:05:03 AM
More...
|
MDRNA, Inc. Announces Third Quarter 2009 Financial Results
11/13/2009 10:03:50 AM
More...
|
MDRNA, Inc. to Present at the 8th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/22/2009 10:20:59 AM
More...
|
MDRNA, Inc. Reports UsiRNA Reduces Tumor Growth In Vivo
10/12/2009 11:21:04 AM
More...
|
MDRNA, Inc. Announces Patent Allowance Covering an siRNA With Therapeutic Potential for Oncology and Other Indications
9/29/2009 10:48:01 AM
More...
|
MDRNA, Inc. Adds June D. Ameen to Management Team as Vice President, Corporate Development
9/8/2009 11:12:24 AM
More...
|
MDRNA, Inc. to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
9/3/2009 12:15:52 PM
More...
|
MDRNA, Inc. Appoints James M. Karis to Its Board of Directors
8/11/2009 10:30:42 AM
More...
|
MDRNA, Inc. to Present at the 29th Canaccord Adams Global Growth Conference
8/6/2009 12:20:15 PM
More...
|
MDRNA, Inc. Reports Positive In Vivo Data Demonstrating That Its UsiRNAs Are Highly Potent Against Metabolic and Oncology Targets
8/3/2009 10:20:21 AM
More...
|
|